Identification of "surgical" coronary anatomy by exercise radionuclide cineangiography

Left Ventricular Ejection Fraction Change with Exercise Versus Ejection Fraction at Rest in Coronary Artery Disease: Implications for Using Ejection Fraction Variations in Making Therapeutic Decisions

Previous studies have differed regarding the prognostic importance of the change (Delta) in left ventricular ejection fraction (LVEF) with exercise among patients with known or suspected coronary artery disease (CAD). Data suggest that these discrepancies may be owing to patient selection, including wide interstudy variations in the range of LVEFrest at study entry; however, the impact of LVEFrest on LVEF exercise response has not been adequately addressed. To test the hypothesis that magnitude and variability in DeltaLVEF are systematically related to LVEFrest, we analyzed data from 2655 patients who underwent rest/exercise radionuclide cineangiography for evaluation of clinically evident CAD, stratified into 5 successive LVEFrest subgroups: <30% (n = 205), 30%-44% (n = 563), 45%-59% (n = 1529), 60%-75% (n = 324), and >75% (n = 34). The standard deviation of DeltaLVEF among patients with LVEFrest <30% was found to be half that among patients in the higher LVEFrest subgroups (P < 0.00001, global). The average magnitude of the rise and fall in LVEF with exercise also varied markedly among LVEFrest subgroups (P < 0.0001, global), being smallest among patients with LVEFrest <30%. These findings may explain differences in predictive accuracy of DeltaLVEF noted among various study populations. Further study is needed to determine whether LVEFrest should be used in selecting exercise-based prognostic descriptors in individual patients.

Objective assessment of "cardioprotective" efficacy as a prognostic guide to management of mildly symptomatic revascularizable coronary artery disease

OBJECTIVES

The concept of "cardioprotection" based on ejection fraction was tested to see whether patients with coronary artery disease in whom medical treatment fails to be cardioprotective can be distinguished from those in whom it is safe to continue such treatment.

BACKGROUND

Ejection fraction is of fundamental prognostic importance. Its modification by anti-ischemic medication may allow assessment of cardioprotection from adverse outcome.

METHODS

Exercise ejection fraction and the change in ejection fraction from rest to exercise were measured by radionuclide ventriculography with and without background medication in 102 mildly symptomatic patients with coronary artery disease suitable for revascularization but initially treated medically.

RESULTS

Over 20 months, 23 patients experienced an adverse event. With medication, exercise ejection fraction increased in patients with and without events. By contrast, the ejection fraction response to exercise improved significantly in the event-free group only; the group with events had a persistent decrease in ejection fraction. By Cox analysis, the ejection fraction response to exercise performed with medication made the most significant independent contribution to event-free survival. Comparison of areas under receiver operating characteristic curves suggested that this index is the most useful clinical measure of cardioprotection.

CONCLUSIONS

An exercise-induced decrease in ejection fraction despite anti-ischemic medication implies failure of cardioprotection and a greater short-term risk of adverse outcome and crossover to revascularization in patients initially treated medically. Conversely, a preserved left ventricular performance confers a satisfactory prognosis while continuing with that treatment. Thus, the effect of medication on the ejection fraction response to exercise--a reasonable estimate of its cardioprotective efficacy--may influence the choice of continuing with such treatment or performing early revascularization.

Exercise testing without interruption of medication for refining the selection of mildly symptomatic patients for prognostic coronary angiography

OBJECTIVE

To examine how exercise testing on background medical treatment affects the ability of the test to predict prognostically important patterns of coronary anatomy in patients with a high clinical probability of coronary artery disease but who are well controlled on medication.

DESIGN

Prospective study.

SETTING

Regional cardiothoracic centre and referring district general hospital.

PATIENTS

84 patients with a history of typical angina or definite myocardial infarction and mild symptoms who had been placed on the waiting list for prognostic angiography.

INTERVENTION

Maximal exercise electrocardiography and radionuclide ventriculography performed off and on medication, followed by angiography within three months.

MAIN OUTCOME MEASURE

Prognostically important coronary artery disease for which early surgery might be recommended purely on prognostic grounds, irrespective of symptoms.

RESULTS

Coronary artery disease was present in 71/84 (85%) patients; in 28/84 (33%) patients this was prognostically important. When the result was strongly positive, the predictive accuracy for prognostically important disease was 0.46 off and 0.62 on medication for the exercise electrocardiogram and 0.71 off and 0.82 on medication for exercise radionuclide ventriculography. The likelihood ratio was 1.00 off and 1.36 on medication for exercise electrocardiography and 2.54 off and 10.5 on medication for exercise radionuclide ventriculography. In stepwise logistic regression, the test identified as the strongest predictor of prognostically important disease was exercise radionuclide ventriculography on medication for which the improvement chi 2 was 28 (p < 0.0001). With the regression model, the probability of important disease is 92% if exercise radionuclide ventriculography on medication is at least strongly positive, compared with 16% if the result is normal or just positive.

CONCLUSION

In patients likely to have coronary disease, exercise testing should be performed without interruption of medication to optimise its ability to identify those with prognostically important disease, and to help to avoid unnecessary or premature angiography in those who are well controlled on medical treatment.